The mobile healthcare market is projected to grow from $105.73 billion in 2023 to $137.12 billion in 2024, with a CAGR of 29.7%, driven by the rising prevalence of chronic diseases and advancements in telehealth. By 2028, the market is expected to reach $380.8 billion, reflecting ongoing innovations and integration of technology in healthcare. Key trends include telehealth adoption, wearable technology, and a focus on health equity.
Hims & Hers Health Inc. shares surged by up to 18%, reaching record highs, following the news of President-elect Donald Trump nominating Marty Makary to lead the FDA. Hunterbrook Media highlighted that Makary could be a significant ally for the company, which is involved in selling compounded GLP-1 weight loss drugs. Hunterbrook Capital has shifted its position to long Hims shares, reversing a previous short bet.
Hims & Hers Health Inc. experienced its largest share drop since going public, plummeting 18% after Amazon announced plans to enter the hair-loss drug market, a key area for the telehealth company. Despite a strong performance earlier this year, driven by soaring sales of GLP-1 weight-loss drugs, the news significantly impacted investor confidence.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
